Osteoarticular manifestations of antiphospholipid syndrome

Tektonidou, MG; Moutsopoulos, HM

dc.contributor.author	Tektonidou, MG	en
dc.contributor.author	Moutsopoulos, HM	en
dc.date.accessioned	2014-03-01T01:55:35Z
dc.date.available	2014-03-01T01:55:35Z
dc.date.issued	2006	en
dc.identifier.issn	0889-857X	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/27799
dc.subject.classification	Rheumatology	en
dc.subject.other	SYSTEMIC-LUPUS-ERYTHEMATOSUS	en
dc.subject.other	BONE-MARROW NECROSIS	en
dc.subject.other	HUMAN-IMMUNODEFICIENCY-VIRUS	en
dc.subject.other	HIV-INFECTED PATIENTS	en
dc.subject.other	ACTIVE ANTIRETROVIRAL THERAPY	en
dc.subject.other	CALVE-PERTHES-DISEASE	en
dc.subject.other	AVASCULAR NECROSIS	en
dc.subject.other	FEMORAL-HEAD	en
dc.subject.other	ANTICARDIOLIPIN ANTIBODIES	en
dc.subject.other	RISK-FACTORS	en
dc.title	Osteoarticular manifestations of antiphospholipid syndrome	en
heal.type	journalArticle	en
heal.language	English	en
heal.publicationDate	2006	en
heal.abstract	Antiphospholipid syndrome (APS) is characterized by recurrent throm boses, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL), namely anticardiolipin antibodies (aCL) or lupus anticoagulant (LA) [1,2]. The sundrome is recognized as primary, or it can be associated with other underlying disorders, especially systemic lupus erythematosus (SLE). Thrombosis in APS may occur at any vascular site, and almost every organ system can be affected. However, osteoarticular manifestations in APS have been poorly recognized. Arthralgias represent the most commonly described musculoskeletal manifestations of primary and secondary APS, while arthritis has been primarily reported in SLE-related APS. Osteonecrosis has been described in association with aPL in patients with SLE or APS, as well as in several patients with nonautoimmune disorders.	en
heal.publisher	W B SAUNDERS CO-ELSEVIER INC	en
heal.journalName	RHEUMATIC DISEASE CLINICS OF NORTH AMERICA	en
dc.identifier.isi	ISI:000240218800006	en
dc.identifier.volume	32	en
dc.identifier.issue	3	en
dc.identifier.spage	523	en
dc.identifier.epage	+	en